B. Lynne Parshall

2012

In 2012, B. Lynne Parshall earned a total compensation of $1.2M as Director, Chief Operating Officer, and former Chief Financial Officer at Ionis Pharmaceuticals, a 18% decrease compared to previous year.

Compensation breakdown

Bonus$256,630
Option Awards$198,675
Salary$641,574
Stock Awards$52,136
Other$22,600
Total$1,171,615

Parshall received $641.6K in salary, accounting for 55% of the total pay in 2012.

Parshall also received $256.6K in bonus, $198.7K in option awards, $52.1K in stock awards and $22.6K in other compensation.

Rankings

In 2012, B. Lynne Parshall's compensation ranked 5,518th out of 11,487 executives tracked by ExecPay. In other words, Parshall earned more than 52.0% of executives.

ClassificationRankingPercentile
All
5,518
out of 11,487
52nd
Division
Manufacturing
1,945
out of 4,253
54th
Major group
Chemicals And Allied Products
472
out of 1,198
61st
Industry group
Drugs
314
out of 920
66th
Industry
Pharmaceutical Preparations
245
out of 700
65th
Source: SEC filing on April 26, 2013.

Parshall's colleagues

We found four more compensation records of executives who worked with B. Lynne Parshall at Ionis Pharmaceuticals in 2012.

2012

Stanley Crooke

Ionis Pharmaceuticals

Chief Executive Officer

2012

Richard Geary

Ionis Pharmaceuticals

Senior Vice President, Development

2012

C Bennett

Ionis Pharmaceuticals

Senior Vice President, Antisense Research

2012

Brett Monia

Ionis Pharmaceuticals

Senior Vice President, Antisense Drug Discovery

News

You may also like